You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Merck
since
auto-detected in 40 stories
3 days ago
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
19 days ago
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline ⊖⊖
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
20 days ago
Merck nears $6bn biotech deal to boost cancer drug pipeline ⊖
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
49 days ago
Merck to create separate cancer business to offset Keytruda patent loss ⊖⊖
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
69 days ago
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms ⊕
Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more ○
These are the stocks posting the largest moves in early trading.
70 days ago
Investor Joe Terranova likes Merck despite pharmaceutical firm's move to lower drug price ⊕
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has impacted its business.
3 months ago
Merck in talks to buy cancer drugmaker Revolution Medicines ⊖⊖
US drug company is seeking to acquire the maker of a new treatment for pancreatic cancer
These are the most overbought S&P 500 stocks as 2026 approaches ○
Wall Street's most overbought stocks for the last full trading week of the year included Merck & Co. and S&P Global.
4 months ago
FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm ⊖
There's hope for U.S. cattle ranchers in the battle to stop the spread of screwworm at a time of decimated herds with the FDA approving a new Merck treatment.